glp-1 food industry news today Weight loss drug patients spend less on restaurants, takeout: survey GLP‑1 food trends: What manufacturers

Exploratory models assess doseresponse relationships, tolerability, and sustainability of weightrelated outcomes over multiweek to multimonth protocols

1 Noom notes that there are three essential hurdles that are hindering progress along this front: The cost of medication The sides effects of medication An absence of sustainable behavior change In fact, among patients who begin utilizing GLP-1s, over 50% of them stop as a result of cost, while 36% stop because of side effects

(You can search the NIHR 'Be Part of Research' website, but always discuss eligibility with your clinician) What are the established treatment options that might better address my symptoms

Comprised of Acosta, ActionLink, CORE Foodservice, CROSSMARK, Mosaic, Premium Retail Services, and Product Connections, Acosta Group understands and anticipates evolving consumer needs, fueling accelerated performance to connect tomorrow's commerce today